TEHR vs CareValidate: compare delivery, support and commercial scope

How do the published offers compare as of October 22, 2026?

This table separates a documented offer from an unanswered procurement question. “Not stated on reviewed pages” means we did not establish the term from the cited public material; it does not mean the vendor lacks the capability. TEHR details reflect our stated offering and still require a scoped proposal.

Where does a full-service promise need a responsibility map?

A full-service proposal is useful only when it tells your staff where their work ends and someone else’s begins. Start with a customer asking a commercial question, a patient needing a clinical response and a shipment requiring investigation. These may arrive in the same inbox, but they need different owners and escalation routes. Ask for the coverage hours, response commitments and handoff process for each type of request.

CareValidate’s launch overview describes managed patient support and connections with existing systems. TEHR combines its platform and administrative infrastructure with independent clinical services, with support scope documented in the proposal. Do not assume the two bundles are identical because both use the word support. Map whether your team still handles refunds, subscription changes, identity corrections and communication approvals. This exercise usually exposes more meaningful differences than a homepage feature checklist.

How should you evaluate laboratory workflows?

CareValidate’s laboratory page explicitly describes home collection kits, in-person lab orders and results returning to clinical workflows. That is relevant evidence for a brand considering diagnostics or a program that depends on testing. It does not tell you that every panel, collection method or patient location is included in a single fee. Ask for the proposed test catalog, geographic availability and operational responsibilities for your specific program.

A lab demonstration should follow an incomplete or unsuccessful collection as well as a clean result. Who notices an unusable specimen? Who contacts the patient, arranges the next step and updates the clinical team? How does the portal display a result that is available but not yet reviewed? TEHR lab requirements should be assessed during scoping rather than represented as a verified standalone lab-brand product. The diagnostic lab brand guide helps separate ordering technology, collection logistics and clinical interpretation.

How can you compare costs when a public rate sheet is missing?

An undisclosed price is an open question, not proof that a platform costs more. Send both teams a common request that defines your operating assumptions: expected consultations, recurring orders, support volume, testing needs and any existing systems. Ask them to separate implementation, recurring software, clinical encounters, medications, tests, payment processing and optional services. Avoid comparing one vendor’s platform-only number with another vendor’s bundled proposal.

CareValidate numerical pricing and revenue-share terms were not established in the official pages reviewed for this article. We therefore do not repeat figures from other vendors’ comparison pages. TEHR uses a flat subscription and flat transaction fee with 0% revenue share; contact TEHR for a scoped quote. Once you have comparable proposals, build a base case and a quieter-than-expected case. Startup cash requirements and minimum commitments can matter as much as the cost at your hoped-for scale.

What should the implementation schedule actually measure?

CareValidate’s homepage publishes a 30-day average launch claim. Treat that as a vendor statement about its experience, not a universal date for your business. A useful project plan names prerequisites, acceptance criteria and the owner of each decision. Separate legal and commercial agreements, program configuration, clinical workflow review, payment readiness, testing and operational training. Identify which tasks can run together and which depend on completed approvals.

TEHR can turn a new brand live in under 24 hours with launch essentials ready. There is no required one-to-three-month implementation. A brand bringing an established website and a well-defined program has different work from a team still choosing its offer. Ask both vendors what would delay your specific launch and what can be completed before contracting. The 30-day launch planning guide is a planning scenario rather than a guarantee. A date is useful when everyone knows what must be true before the first patient enters the workflow.

When should you choose TEHR?

Choose TEHR if its brand-facing software and proposed administrative services fit the way you want to run commerce, subscriptions and patient relationships. TEHR’s operators built DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. Ask them to translate that experience into concrete work for your business: catalog setup, support routing, subscription exceptions and continuity during a transition.

The decision should rest on the proposal you receive. Confirm which tasks are included, which are optional and which remain with your team or an independent clinical partner. Review the platform workflow alongside commercial terms, then bring the unresolved steps to a TEHR demonstration. TEHR does not practice medicine or prescribe. A brand can outsource substantial operational work while still needing a clear boundary between its business decisions and a clinician’s judgment about an individual patient.

When should you choose CareValidate?

Choose CareValidate when the specific combination of laboratory connections, managed support and clinical operations in its written scope fits your delivery needs. Its provider-network page describes credentialing and staffing under the customer’s brand. For a business that expects testing and service coordination to drive daily workload, those capabilities deserve a detailed demonstration instead of being treated as peripheral features.

The tradeoff is the need to establish commercial and implementation details that were not public in the reviewed material. Ask how existing pharmacy or EHR relationships are connected, how change requests are priced and how service ownership is documented. If marketing or growth assistance is proposed, define its deliverables separately from clinical and software services. A broad service partner can be a strong fit, but the buyer should be able to identify which deliverable addresses which operational problem.

What does an existing patient base change?

An existing brand is buying continuity as well as new capability. Document active patients, upcoming appointments, open orders, incomplete tests, prescription history and recurring billing before requesting a transition schedule. Ask for a lawful transfer process, sample mapping and clear acceptance criteria. Clinical care and recurring commercial charges should not be assumed to move merely because demographic records import successfully.

CareValidate migration commitments were not established on the reviewed pages. That is a question to ask, not a claim that migration is unavailable. TEHR’s experience also needs to be mapped to your particular systems and records. Use the patient migration checklist to compare proposed validation, exception handling and transition communications. Preserve access to historical information for the purposes and duration required by your actual agreements and applicable obligations; resolve those details with the parties responsible before cutover.

How do you turn the comparison into a decision?

Give the finalists three realistic cases: a straightforward new patient, an established patient with an unresolved order and a patient whose next step requires extra review. Ask the operator, support and clinical representatives to explain how each case moves through the system. Watch for an answer that changes when the sales demonstration ends and the implementation discussion begins.

Then compare the evidence you have: an itemized commercial schedule, a responsibility map, a sample workflow and a scoped launch or migration plan. A vendor that leaves a question unanswered should receive a follow-up request, not a fabricated negative rating. For a wider shortlist, use CareValidate alternatives. If the infrastructure categories still feel blurred, the white-label telehealth guide explains what software, clinical services and business operations each contribute.

What else should you know?